Douglas Kerr's Net Worth
$3.81 Million
Who is Douglas Kerr?
Douglas Kerr has an estimated net worth of $3.81 Million. This is based on reported shares across multiple companies, which include Generation Bio Co., and Dyne Therapeutics, Inc..
SEC CIK
Douglas Kerr's CIK is 0001814189
Past Insider Trading and Trends
2021 was Douglas Kerr's most active year for acquiring shares with 6 total transactions. Douglas Kerr's most active month to acquire stocks was the month of December. 2021 was Douglas Kerr's most active year for disposing of shares, totalling 21 transactions. Douglas Kerr's most active month to dispose stocks was the month of December. 2021 saw Douglas Kerr paying a total of $245,910.99 for 124,891 shares, this is the most they've acquired in one year. In 2021 Douglas Kerr cashed out on 102,782 shares for a total of $1,553,110.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Generation Bio Co. (GBIO) Snapshot price: $2.18
CHIEF MEDICAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.93% | 3.54K |
$1.90 | -$2,804.40 | 385.63K |
Jan 29
| |||
Form 4
| +2.48% | 9.23K |
$1.91 | -$9,353.27 | 382.08K |
Jan 15
| |||
Form 4
| +1.44% | 5.25K |
$3.24 | -$7,072.92 | 370.4K |
Oct 15
| |||
Form 4
| +1.46% | 5.25K |
$5.08 | -$11,089.64 | 365.15K |
Jul 15
| |||
Form 4
| +1.49% | 5.25K |
$4.50 | -$9,823.50 | 356.78K |
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
| +1.40% | 4.86K |
$5.10 | -$13,147.80 | 351.53K |
Jan 15
| |||
Form 4
| +1.55% | 5.25K |
$5.61 | -$12,252.24 | 344.8K |
Oct 15
| |||
Form 4
| +3.19% | 10.51K |
$7.18 | -$31,355.06 | 339.55K |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
$15.18 | -$70,517.54 | 326.56K |
Scheduled
|
Jul 8
| ||
Form 4
|
—
|
0
|
$17.63 | -$350,839.17 | 326.56K |
Scheduled
|
Apr 5
| ||
Form 4
|
—
|
0
|
$18.02 | -$302,551.63 | 326.56K |
Scheduled
|
Mar 5
| ||
Form 4
|
—
|
0
|
$18.98 | -$324,238.83 | 326.56K |
Scheduled
|
Feb 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
$16.09 | -$259,052.34 | 326.56K |
Scheduled
|
Jan 11
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dyne Therapeutics, Inc. (DYN) Snapshot price: $33.03
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 47.5K |
—
|
—
| 47.5K |
Sep 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||